Xtant Medical Holdings, Inc. (XTNT), a global medical technology company, Tuesday said it has agreed to sell certain Coflex and CoFix interlaminar stabilization implant assets and all OUS entities of Paradigm Spine GmbH, to Companion Spine, LLC for $19.2 million, including $11 million in cash and $8.2 million in short-term seller financing.
Xtant plans to use the proceeds to reduce long term debt and to improve liquidity.
Additionally, the company intends to transition certain members of the Xtant U.S. and international commercial organizations, who will continue to support these products.
The deal is expected to close in the third quarter of 2025.
"This transaction is a significant step for us as we focus on our core business - the development of higher-margin, best-in-class orthobiologics - while also strengthening our balance sheet and streamlining our operations," said Sean Browne, President and CEO of Xtant Medical.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.